Nykredit A/S’s ResMed RMD Stock Holding History

Nykredit A/S’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66M	Buy	+338,702	New	+$70.2M	0.21%	96

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's RMD Position: Q2 2026 in Review

Nykredit A/S opened a new position in ResMed (RMD) in Q2 2026: 338,702 shares worth $66M. The stake represents 0.21% of the portfolio and ranks #96 among its holdings.

673 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Nykredit A/S held 338,702 shares of ResMed worth $66M as of Q2 2026.
ResMed was a new Nykredit A/S position in Q2 2026.
ResMed made up 0.21% of Nykredit A/S's portfolio in Q2 2026, its #96 holding.
673 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.